Table 5.
Demographics, clinical characteristics and outcome data.
| Variables | ENTIRE cohort n = 55 | ACLF n= 44 (80%) | AD n=11 (20%) |
|---|---|---|---|
| Age* | 60.0±11.1 | 52.9±11.2 | 53.4±11.5 |
|
| |||
| Male | 40 (72%) | 33 (60%) | 7 (13%) |
|
| |||
| Etiology | |||
| Viral | 15 (27%) | 12 (27%) | 3 (27%) |
| Alcohol | 25 (46%) | 22 (50%) | 3 (27%) |
| Other | 15 (27%) | 10 (23%) | 5 (46%) |
|
| |||
| CPC | |||
| Class B | 7 (13%) | 2 (5%) | 5 (45%) |
| Class C | 48 (87%) | 42 (95%) | 6 (55%) |
|
| |||
| MELD* | 28.4±9 | 31.0±6.7 | 16.0±6.6 |
|
| |||
| Outcome | |||
| LT | 30 (55%) | 22 (50%) | 8 (73%) |
| Death | 20 (36%) | 19 (43%) | 1 (9%) |
| Survivors without LT | 5 (9%) | 3 (7%) | 2 (18%) |
|
| |||
| CLIF-C ACLF | – | 54.5±24.8 | – |
|
| |||
| CLIF-C AD | – | – | 55.7±28.3 |
CPC – Child-Pugh class; MELD – Model of End-Stage Liver Disease; LT – liver transplantation; The data are presented as mean±SD and numbers with percentage in brackets, where appropriate.